TuHURA Biosciences/$HURA
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About TuHURA Biosciences
TuHURA Biosciences Inc is a phase 3 clinical stage immuno-oncology company with three distinct technologies focused on the development of novel therapeutics designed to overcome primary and acquired resistance to cancer immunotherapies. The company's personalized cancer vaccine candidate, IFx-2.0, is designed to overcome primary resistance to checkpoint inhibitors. The company operates in one reportable segment, which includes all activities related to advancing therapies for cancer treatment.
Ticker
$HURA
Sector
Primary listing
Employees
22
Headquarters
Website
HURA Metrics
BasicAdvanced
$148m
-
-$0.63
-
-
Price and volume
Market cap
$148m
52-week high
$4.20
52-week low
$0.41
Average daily volume
1.2m
Financial strength
Current ratio
0.781
Quick ratio
0.724
Long term debt to equity
1.451
Total debt to equity
3.344
Interest coverage (TTM)
-44.97%
Profitability
EBITDA (TTM)
-28.045
Management effectiveness
Return on assets (TTM)
-74.27%
Return on equity (TTM)
-169.18%
Valuation
Price to book
6.69
Price to tangible book (TTM)
13.94
Price to free cash flow (TTM)
-4.029
Free cash flow yield (TTM)
-24.82%
Free cash flow per share (TTM)
-0.578
Growth
Earnings per share change (TTM)
-48.32%
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
Capital at risk
Upcoming events
No upcoming events
FAQs
What’s the current market cap for TuHURA Biosciences stock?
TuHURA Biosciences (HURA) has a market cap of $148M as of May 04, 2026.
What is the P/E ratio for TuHURA Biosciences stock?
The price to earnings (P/E) ratio for TuHURA Biosciences (HURA) stock is 0 as of May 04, 2026.
Does TuHURA Biosciences stock pay dividends?
No, TuHURA Biosciences (HURA) stock does not pay dividends to its shareholders as of May 04, 2026.
When is the next TuHURA Biosciences dividend payment date?
TuHURA Biosciences (HURA) stock does not pay dividends to its shareholders.
What is the beta indicator for TuHURA Biosciences?
TuHURA Biosciences (HURA) does not currently have a Beta indicator.